Stay updated on Risankizumab vs Secukinumab in Psoriasis Clinical Trial
Sign up to get notified when there's something new on the Risankizumab vs Secukinumab in Psoriasis Clinical Trial page.

Latest updates to the Risankizumab vs Secukinumab in Psoriasis Clinical Trial page
- ChecktodayChange DetectedA new line '2017 ( U.S. NIH Grant/Contract )' was added. The site revision was updated to v3.6.6, replacing the previous v3.6.5.SummaryDifference0.1%

- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedRevision: v3.6.5 has been added, replacing the previous Revision: v3.6.4. This is a platform version update and does not change the study content on the page.SummaryDifference0.0%

- Check36 days agoChange DetectedNow shows Revision: v3.6.4 in the data-sharing section. This reflects an update to the underlying software version used for IPD data sharing.SummaryDifference0.0%

- Check57 days agoChange DetectedThe revision label on the page updated to v3.6.3, indicating a behind-the-scenes update to the platform. This change does not alter the study details or user-facing content.SummaryDifference0.0%

- Check64 days agoChange DetectedThe page footer now displays Revision: v3.6.2, replacing the previous v3.6.0.SummaryDifference0.0%

- Check78 days agoChange DetectedThe page now indicates recruitment has closed and adds new help sections (How to Read a Study Record, Common Questions, How to Join a Study). It also adjusts the Intervention/Treatment heading and updates the revision to v3.6.0.SummaryDifference0.3%

Stay in the know with updates to Risankizumab vs Secukinumab in Psoriasis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Risankizumab vs Secukinumab in Psoriasis Clinical Trial page.